Regeneron Pharmaceuticals | REGN - PE Price to Earnings


Regeneron Pharmaceuticals reported 15.46 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AbbVie 23.45 0.51 Sep/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 13.17 62.47 Sep/2026
Amgen 18.6 0.53 Sep/2026
Astellas Pharma 9.57 0.16 Sep/2026
AstraZeneca 24.63 0.71 Sep/2026
Biogen 29.15 5.92 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Bristol-Myers Squibb 10.44 5.7 Sep/2026
Eli Lilly 64.5 31.61 Sep/2026
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Incyte 54.54 40.08 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 25.86 3.57 Sep/2026
Kyowa Hakko Kirin 12.16 4.23 Sep/2026
Merck 34.36 2.11 Sep/2026
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 83.17 61.07 Sep/2026
Novartis 19.17 3.24 Sep/2026
Novartis 21.54 0.18 Sep/2026
Pfizer 15.2 3.72 Sep/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 21.74 11.35 Sep/2026
Sarepta Therapeutics 54.75 27.48 Jun/2026
Teva Pharmaceutical Industries 18.7 5.9 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026